down arrow

Guj. Themis Bio.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE942C01045
  • NSEID: GUJTHEM
  • BSEID: 506879
INR
267.05
20.15 (8.16%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 1.01 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Rs cr
Standalone Annual Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Mar'18
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2024 is 14.44% vs 29.20% in Mar 2023

stock-summary

Standalone Net Profit

YoY Growth in year ended Mar 2024 is 2.05% vs 32.90% in Mar 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2024 is 6.93% vs 26.88% in Mar 2023

stock-summary

Interest

YoY Growth in year ended Mar 2024 is 27.78% vs -78.31% in Mar 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2024 has fallen from Mar 2023

Compare Annual Results Of Guj. Themis Bio. With
Markets Mojo
Figures in Rs cr
Standalone Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
169.82
8,558.51
-8,388.69
-98.02%
Other Operating Income
0.00
0.00
0.00
Total Operating income
169.82
8,558.51
-8,388.69
-98.02%
Raw Material Cost
25.67
859.11
-833.44
-97.01%
Purchase of Finished goods
0.00
1,825.86
-1,825.86
-100.00%
(Increase) / Decrease In Stocks
11.01
-60.74
71.75
118.13%
Employee Cost
11.41
1,890.84
-1,879.43
-99.40%
Power Cost
26.53
0.00
26.53
Manufacturing Expenses
4.93
0.00
4.93
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
11.53
1,859.00
-1,847.47
-99.38%
Total Expenditure (Excl Depreciation)
91.08
6,374.07
-6,282.99
-98.57%
Operating Profit (PBDIT) excl Other Income
78.74
2,184.44
-2,105.70
-96.40%
Other Income
4.37
266.64
-262.27
-98.36%
Operating Profit (PBDIT)
83.11
2,451.08
-2,367.97
-96.61%
Interest
0.23
14.57
-14.34
-98.42%
Exceptional Items
0.00
103.53
-103.53
-100.00%
Gross Profit (PBDT)
82.88
2,436.51
-2,353.63
-96.60%
Depreciation
3.54
317.46
-313.92
-98.88%
Profit Before Tax
79.33
2,119.05
-2,039.72
-96.26%
Tax
20.17
399.17
-379.00
-94.95%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
59.16
1,719.88
-1,660.72
-96.56%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
103.53
-103.53
-100.00%
Net Profit
59.16
1,823.41
-1,764.25
-96.76%
Equity Capital
7.26
40.06
-32.80
-81.88%
Face Value
1.00
1.00
0.00
Reserves
194.11
9,583.75
-9,389.64
-97.97%
Earnings per share (EPS)
5.43
45.52
-40.09
-88.07%
Diluted Earnings per share
8.14
45.45
-37.31
-82.09%
Operating Profit Margin (Excl OI)
46.37%
25.52%
0.00
20.85%
Gross Profit Margin
48.80%
28.47%
0.00
20.33%
PAT Margin
34.84%
20.10%
0.00
14.74%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 169.82 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 14.44% vs 29.20% in Mar 2023

Annual - Standalone Net Profit
Standalone Net Profit 59.16 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 2.05% vs 32.90% in Mar 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 78.74 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 6.93% vs 26.88% in Mar 2023

Annual - Interest
Interest 0.23 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 27.78% vs -78.31% in Mar 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 46.37%
in Mar 2024

Figures in Rs %
stock-summary

YoY Growth in year ended Mar 2024 has fallen from Mar 2023